• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Abliva

Less than 1K followers
All
Webcasts
Press releases
3rd party
ShowingAll content types

Press release3/17/2025, 11:05 AM

BioStock: Sista handelsdag för Abliva - bolaget lämnar Nasdaq Stockholm

Abliva
Press release3/17/2025, 11:05 AM

BioStock: Last trading day for Abliva - the company leaves Nasdaq Stockholm

Abliva
Regulatory press release3/3/2025, 12:10 PM

Avnotering av aktierna i Abliva: sista handelsdag 17 mars 2025

Abliva

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release3/3/2025, 12:10 PM

Delisting of the shares of Abliva: last day of trading 17 March 2025

Abliva
Regulatory press release2/26/2025, 7:30 AM

Kallelse till extra bolagsstämma i Abliva AB (publ)

Abliva
Regulatory press release2/26/2025, 7:30 AM

Notice of Extraordinary General Meeting in Abliva AB (publ)

Abliva
Regulatory press release2/25/2025, 8:50 AM

Abliva ansöker om avnotering och kommer att kalla till extra bolagsstämma

Abliva
Regulatory press release2/25/2025, 8:50 AM

Abliva applies for delisting and will convene an extraordinary general meeting

Abliva
Press release2/24/2025, 4:30 PM

Penser Access & Future by Carnegie: Abliva: Uppköpsprocessen nästan färdigställd

Abliva
Regulatory press release2/21/2025, 1:40 PM

Finansinspektionen: Flaggningsmeddelande i Abliva AB

Abliva
Press release2/21/2025, 7:42 AM

BioStock: Pharming Technologies avslutar Abliva-affären - tvångsinlösen inledd

Abliva
Regulatory press release2/21/2025, 7:30 AM

Abliva AB Bokslutskommuniké januari – december 2024

Abliva
Regulatory press release2/21/2025, 7:30 AM

Abliva AB Year-End Report January – December 2024

Abliva
Regulatory press release2/12/2025, 10:36 AM

Finansinspektionen: Flaggningsmeddelande i Abliva AB

Abliva
Regulatory press release2/11/2025, 2:51 PM

Finansinspektionen: Flaggningsmeddelande i Abliva AB

Abliva
Press release2/10/2025, 9:43 AM

BioStock: Pharming fullföljer bud på Abliva

Abliva
Press release2/10/2025, 9:43 AM

BioStock: Pharming completes bid for Abliva

Abliva
Press release12/16/2024, 7:00 AM

Penser Access & Future by Carnegie: Abliva: Uppköpserbjudande från Pharming

Abliva
Regulatory press release12/15/2024, 7:00 PM

Uttalande från Ablivas styrelse med anledning av Pharmings kontanta offentliga uppköpserbjudande

Abliva
Regulatory press release12/15/2024, 7:00 PM

Statement by the Board of Directors of Abliva regarding the public cash offer from Pharming

Abliva